A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
This is a Phase IIa study to evaluate the efficacy, safety and tolerability of GW679769 vs
placebo on symptoms of urgency with urge incontinence, frequency and nocturia associated with
overactive bladder in women.